Gellai, Miklos
GlaxoSmithKline plc.,
United Kingdom
2025 Rank: 257352
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2537 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 257352 | 278310 |
| Total Cites | 1985 | 2136 |
| H-index | 26 | 28 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 91 | 91 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 735 | 779 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 1024 | 1092 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1595 | 1666 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
7.07%
|
|
Gellai, Miklos
GlaxoSmithKline plc.,
United States
2024 Rank: 240173
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2390 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 240173 | 260353 |
| Total Cites | 1954 | 2098 |
| H-index | 26 | 28 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 89 | 89 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 726 | 770 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 1009 | 1076 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1572 | 1641 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
6.86%
|
|
Gellai, Miklos
GlaxoSmithKline plc.,
United States
2023 Rank: 224089
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2281 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 224089 | 243311 |
| Total Cites | 1929 | 2072 |
| H-index | 26 | 28 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 86 | 86 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 718 | 762 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 996 | 1063 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1548 | 1616 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
6.90%
|
|
Gellai, Miklos
GlaxoSmithKline plc.,
United States
2022 Rank: 209456
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2157 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 209456 | 227600 |
| Total Cites | 1898 | 2040 |
| H-index | 26 | 28 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 83 | 83 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 704 | 748 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 977 | 1044 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1519 | 1587 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.29 |
| Self-Citation Percentage |
6.96%
|
|
Gellai, Miklos
GlaxoSmithKline plc.,
United States
2021 Rank: 201891
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2103 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 201891 | 222854 |
| Total Cites | 1862 | 1999 |
| H-index | 26 | 27 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 78 | 78 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 691 | 731 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 958 | 1021 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1488 | 1556 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
6.85%
|
|
Gellai, Miklos
GlaxoSmithKline plc.,
United States
2020 Rank: 181941
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1771 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 181941 | 201017 |
| Total Cites | 1830 | 1967 |
| H-index | 26 | 27 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 76 | 76 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 681 | 721 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 942 | 1005 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1460 | 1528 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.29 |
| Self-Citation Percentage |
6.96%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.